Polyrizon Ltd.

US$11.04As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:PLRZHealthcare
Country USA
PE (Fwd) •••
TSR 2Y CAGR (92.50%)
Div yield —
ROE (21.42%)
Biotechnology
Beta (5Y) (1.11)
PE TTM —
TSR TTM 80.47%
Mkt cap US$26.82M
ROIC (23.74%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$13
14.99%
451.51%
Hold 4|1|9|11|6
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.27
0.27
0.26
0.26
21.48%
15.06%
1.61%
(7.04%)
Revenue$M
2.643
2.662
2.694
2.673
(1.70%)
0.71%
4.76%
6.72%
Peers (US$26.82M)
Cap (US$)
PE
24.41M
—
15.25M
—
Capital
TTM
5Y
10Y
Leveragex
1.088
(0.568)
(0.397)
EBIT/Intx
0.149
0.088
0.081
Own earn%
71.89
(2.67)
(0.34)
Sh yield%
33.42
24.15
25.57
Owners
Insiders/Inst%
13.29
54.76
Short interest%
3.48
SBC / revenue%
2.02
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
13
Op margin range%
0–6
$1 testx
0.1
Incr. ROIC%
7